ChronoScale (CHRN) EBITDA (2012 - 2026)

ChronoScale (CHRN) has 15 years of EBITDA data on file, last reported at -$6.7 million in Q1 2026.

• EBITDA for Q1 2026 came in at -$6.7 million, down 94.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$16.6 million (down 53.44% YoY), and the FY2025 annual result was -$13.3 million, down 26.74% from the prior year.
• EBITDA eased to -$6.7 million in Q1 2026 per CHRN's latest filing, from -$4.7 million in the prior quarter.
• Over five years, EBITDA peaked at -$1.4 million in Q3 2025 and troughed at -$6.7 million in Q1 2026.
• A 5-year average of -$3.6 million and a median of -$3.7 million in 2022 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2024: EBITDA sank 115.2% in 2022, then jumped 45.19% in 2024.
• A 5-year view of EBITDA shows it stood at -$4.1 million in 2022, then gained by 7.56% to -$3.8 million in 2023, then jumped by 34.9% to -$2.5 million in 2024, then sank by 89.06% to -$4.7 million in 2025, then slumped by 43.06% to -$6.7 million in 2026.
• Business Quant data shows CHRN's EBITDA at -$6.7 million in Q1 2026, -$4.7 million in Q4 2025, and -$1.4 million in Q3 2025.